-

Navitus Health Solutions Partners with Virta Health to Address Type 2 Diabetes and Obesity Epidemics

Amid rising prevalence of type 2 diabetes, prediabetes and obesity, Navitus offers clients a solution to help members improve their health while reducing dependence on expensive medications

MADISON, Wis.--(BUSINESS WIRE)--Navitus Health Solutions announced today a partnership with Virta Health, making Virta’s industry-leading solutions for reversal of type 2 diabetes, prediabetes, and obesity available to Navitus clients. This will augment existing and emerging solutions to support payors that seek to manage these conditions within their member populations.

The rising prevalence and associated costs of these conditions remain concerns for employers and health plans, noting the long-term health impacts as well as rising preference for expensive glucagon-like peptide-1 (GLP-1) agonist drugs.

Virta’s effective peer-reviewed solutions combine provider-led virtual care with personalized nutrition to help people with type 2 diabetes, prediabetes, and obesity lose weight and/or lower their blood sugar levels while reducing or eliminating the need for costly medications for those on or considering drug therapy.

“Navitus has 20 years of experience lowering costs for plan sponsors while helping members access clinically appropriate care,” says Laura Jester, Vice President, Clinical Services at Navitus. “This partnership builds upon our proven track record. Our clients look to us for transformational solutions to chronic diseases. Virta offers just that—a tech-forward approach that lowers drug spend for utilizing members while improving member health.”

“Payors want innovative solutions to the chronic disease cost crisis, especially amid the rise in use of GLP-1s. With this partnership, Navitus clients can seamlessly plug Virta into the list of benefits and watch healthcare costs go down,” said Kevin Kumler, President at Virta Health. “More importantly, millions of people now have access to the life-changing benefits of reversing their condition.”

About Navitus
Navitus Health Solutions, LLC, owned by SSM Health and Costco Wholesale Corporation, was founded in 2003 as an alternative to traditional pharmacy benefit management (PBM) models. Navitus approaches pharmacy services differently. We are purpose-driven to help humans and committed to removing cost from the drug supply chain to make medications more affordable for the people who need them. We proudly serve over 11 million people through more than 1,000 plan sponsor and health plan client relationships. Our transparent, fully pass-through model enables clients to achieve their goals and drive desired health and financial outcomes. To learn more about Navitus, visit navitus.com.

About Virta Health
Virta Health is the leader in the reversal of chronic conditions, and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. Our virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation’s largest organizations, including Humana, AutoZone, and Blue Shield of California. They also deliver industry-leading cost savings of over $6,000 per member per year while putting their fees at risk based on health outcomes. To learn more, visit www.virtahealth.com.

Contacts

For questions and media inquiries, contact Navitus@allisonworldwide.com

Navitus Health Solutions, LLC


Release Versions

Contacts

For questions and media inquiries, contact Navitus@allisonworldwide.com

More News From Navitus Health Solutions, LLC

Navitus Launches GLP-1 Pathways and DirectAccess

MADISON, Wis.--(BUSINESS WIRE)--As employers and other plan sponsors grapple with rising demand for GLP-1 medications and the financial challenges associated with them, Navitus today launched GLP-1 Pathways, a comprehensive approach to managing these therapies across the full treatment journey. The new offering includes DirectAccess, a direct-to-consumer option that provides eligible members access to GLP-1 medications for weight management outside the traditional pharmacy benefit. DirectAccess...

Navitus Helps Industry Prepare for Biggest Pharmacy Standard Change in Decades

MADISON, Wis.--(BUSINESS WIRE)--As the pharmacy industry launches its most significant technology transition in decades, Navitus is helping clients and partners move to the new federal standard for claims and other information vital for all prescription transactions. The switch to the National Council for Prescription Drug Programs’ new F6 standard affects every organization involved in real-time prescription transactions, including pharmacy benefit managers (PBMs) such as Navitus, pharmacies,...

Navitus releases Drug Trend Report, “Clarity for Action”

MADISON, Wis.--(BUSINESS WIRE)--Navitus today released its 10th annual Drug Trend Report, “Clarity for Action,” the company’s flagship annual analysis of prescription drug cost trends. The report details how utilization growth and therapeutic innovation drove prescription drug costs in 2025 and outlines clear actions for health plans and plan sponsors to counter accelerating pressure. Across the Navitus commercial book of business, net prescription drug costs increased 8.4%, up from 7% in 2024,...
Back to Newsroom